High Levels of the PSA (Prostate Specific Antigen) In Patients with Benign Prostatic Hyperplasia and Prostate CancerRishu BansaliMedPub
Prostate-specific antigen (PSA) is the tumor marker most widely used in conjunction with digital rectal examination (DRE) for the early detection of prostate cancer (PCa). Due to its limitations, especially the high rate of false positive (FP) results, PSA screening of transplant candidates is...
Prostate-specific antigen (PSA) is a glycoprotein produced by epithelial cells of the prostate gland. PSA serum levels are increased in prostate cancer (PCa) due to the disruption of the tissue barriers between the prostate gland and the capillaries, which lead to a higher release into the bloo...
Lung volume, airway resistance, and compliance have been measured in 19 infants, 18 of whom suffered from the respiratory distress syndrome (RDS) at birth, while the remaining infant was ventilated for persistent apnea and a pneumothorax. Prior to discharge from the neonatal unit, and after recov...
Blood PSA testing is used as a screening test for prostate cancer. Prostate-specific antigen (PSA) levels by age remain the same across most populations. A PSA level above 4.0 ng/mL in any age group must be investigated. However, PSA levels can spike in noncancerous conditions, such as ...
BACKGROUNDThe prostate produces high levels of prostate-specific antigen (PSA), which has been shown to exert anti-angiogenic properties and thus might slo... Johanna,M.,Mattsson,... - 《Prostate》 被引量: 69发表: 2008年 Theoretical Study of the Structural Properties and Equations of State ...
aMonitoring with PSA after treatment for prostate cancer is a mainstay of clinical practice, although the clinical utility of PSA is variable and depends on the disease stage of the indi-vidual patient. As has recently been observed, the lack of high quality information and paucity of clinical...
et al. Somatic mutations throughout the entire mitochondrial genome are associated with elevated PSA levels in prostate cancer patients. Am. J. Hum. Genet. 87, 802–812 (2010). 43 Ottoni, C., Martinez-Labarga, C., Vitelli, L., Scano, G., Fabrini, E., Contini, I. et al. Human ...
High-grade prostate cancer, also called poorly differentiated prostate cancer, has Gleason scores from 8 to 10. Based on preoperative parameters (clinical stage, initial PSA and Gleason Score), Yossepowitch et al. [1] defined eight different categories amongst high risk prostate cancer (HRPC) ...
Although the widespread use of prostate-specific antigen (PSA) testing has led to an increase in the number of cancers detected, controversies about the benefits of screening persist. No conclusive evidence has yet emerged that PSA screening reduces the mortality associated with prostate cancer. Thus...